WebNovartis CCTL019A2205B; MT2015-16R: Long Term Follow-Up. Bachanova, Veronika (PI) Clinical and Translational Science Institute; Medicine - Hematology, Oncology, Transplant; Project: Research project. Overview; Fingerprint; Fingerprint. Explore the research topics touched on by this project. These labels are generated based on the underlying ... Web• CCTL019A2205B: Long-term follow-up of patients exposed to lentiviral-based CD19 directed CAR-T-cell therapy. • CCTL019B2401: A registry to assess the long term safety of patients with B lymphocyte malignancies treated with tisagenlecleucel. Table 4 Important identified risk: Serious neurological adverse reactions Evidence for linking the
History of Changes for Study: NCT02445222
WebCCTL019A2205B PI: Jonathon B. Cohen, MD, MS Contact the Clinical Trials Office at Winship for more info, call (404) 778-4400 or email [email protected]. Learn … WebMay 1, 2015 · ID Number: CCTL019A2205B NCT Identifier: NCT02445222 NCT02445222, February 03, 2024 Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database. genie silentmax 1000 flashing red light
Errata to FDA Briefing Document Oncologic Drugs …
WebSponsor Protocol Number: CCTL019A2205B About this study Per Health Authorities guidelines for gene therapy medicinal products that utilize integrating vectors (e.g. … WebProtocol No. CCTL019A2205B: Long Term Follow -up of Patients Exposed to Lentiviral - Based CD19 directed CART Cell Therapy WebThe EU Clinical Trials Register currently displays 43433 clinical trials with a EudraCT protocol, of which 7184 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006). genie silentmax wall console